The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage. Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing, especially analysis of HER2 status, microsatellite instability (MSI) status, and the expression of programmed death-ligand 1 (PD-L1), has had a significant impact on clinical practice and patient care. Targeted therapies including trastuzumab, nivolumab, and pembrolizumab have produced encouraging results in clinical trials for the treatment of patients with locally advanced or metastatic disease. Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, is recommended for all patients with unresectable or metastatic cancer. Multidisciplinary team management is essential for all patients with localized gastric cancer. This selection from the NCCN Guidelines for Gastric Cancer focuses on the management of unresectable locally advanced, recurrent, or metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Self-citationBang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Self-citationGlobal Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J.-P., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02105 · Cited by 3,048
Janjigian, Y. Y., Shitara, K., Moehler, M., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00797-2 · Cited by 3,041
Self-citationThe clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714448 · Cited by 2,824
Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H. C., Kindler, H. L., Lopez-Martin, J. A., Miller, W. H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30445-9 · Cited by 2,552
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Self-citationFuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
Van Cutsem, E., Moiseyenko, V. M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8429 · Cited by 1,926
Self-citationGastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790
Fuchs, C. S., Doi, T., Jang, R. W., Muro, K., Satoh, T., Machado, M., Sun, W., Jalal, S. I., Shah, M. A., Metges, J.-P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0013 · Cited by 1,784
Self-citationKarnofsky performance status revisited: reliability, validity, and guidelines.
Schag, C. C., Heinrich, R. L., & Ganz, P. A. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.3.187 · Cited by 1,517
Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer
Shitara, K., Bang, Y.-J., Iwasa, S., Sugimoto, N., Ryu, M.-H., Sakai, D., Chung, H.-C., Kawakami, H., Yabusaki, H., Lee, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004413 · Cited by 1,333
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Hofmann, M., Stoss, O., Shi, D., Büttner, R., Van De Vijver, M., Kim, W., Ochiai, A., Rüschoff, J., & Henkel, T. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03028.x · Cited by 1,187
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184
Gastric cancer: epidemiology, prevention, classification, and treatment
Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, J., Maciejewski, R., & Polkowski, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s149619 · Cited by 1,026
Glimelius, B., Ekström, K., Hoffman, K., Graf, W., Sjödén, P.-O., Haglund, U., Svensson, C., Enander, L.-K., Linné, T., Sellsröm, H., et al. (1997) · Annals of Oncology · doi:10.1023/a:1008243606668 · Cited by 849
Al-Batran, S.-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9378 · Cited by 782
Kang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn717 · Cited by 764
Tanner, M., Hollmén, M., Junttila, T. T., Kapanen, A. I., Tommola, S., Soini, Y., Helin, H., Salo, J., Joensuu, H., Sihvo, E., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi064 · Cited by 665
Rüdiger Siewert, J., Feith, M., Werner, M., & Stein, H. J. (2000) · Annals of Surgery · doi:10.1097/00000658-200009000-00007 · Cited by 662
Kang, J. H., Lee, S. I., Lim, D. H., Park, K.-W., Oh, S. Y., Kwon, H.-C., Hwang, I. G., Lee, S.-C., Nam, E., Shin, D. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4585 · Cited by 660
Etemadi, A., Safiri, S., Sepanlou, S. G., Ikuta, K., Bisignano, C., Shakeri, R., Amani, M., Fitzmaurice, C., Nixon, M., Abbasi, N., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30328-0 · Cited by 635
Evaluation of Chemotherapeutic Agents.
(1950) · Annals of Internal Medicine · doi:10.7326/0003-4819-32-1-168_1 · Cited by 618
Thuss-Patience, P. C., Kretzschmar, A., Bichev, D., Deist, T., Hinke, A., Breithaupt, K., Dogan, Y., Gebauer, B., Schumacher, G., & Reichardt, P. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.002 · Cited by 612
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Van Cutsem, E., Bang, Y.-J., Feng-yi, F., Xu, J. M., Lee, K.-W., Jiao, S.-C., Chong, J. L., López-Sanchez, R. I., Price, T., Gladkov, O., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0402-y · Cited by 608
Ford, H. E. R., Marshall, A., Bridgewater, J. A., Janowitz, T., Coxon, F. Y., Wadsley, J., Mansoor, W., Fyfe, D., Madhusudan, S., Middleton, G. W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70549-7 · Cited by 595
Jeurnink, S. M., Steyerberg, E. W., van Hooft, J. E., van Eijck, C. H. J., Schwartz, M. P., Vleggaar, F. P., Kuipers, E. J., & Siersema, P. D. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.09.042 · Cited by 556
Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.154 · Cited by 524
Shitara, K., Doi, T., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30739-3 · Cited by 511
Self-citationRüschoff, J., Dietel, M., Baretton, G., Arbogast, S., Walch, A., Monges, G., Chenard, M.-P., Penault-Llorca, F., Nagelmeier, I., Schlake, W., et al. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0952-2 · Cited by 486
Molecular characterization of cancers with NTRK gene fusions
Gatalica, Z., Xiu, J., Swensen, J., & Vranic, S. (2019) · Modern Pathology · doi:10.1038/s41379-018-0118-3 · Cited by 486
Sano, T., Coit, D. G., Kim, H. H., Roviello, F., Kassab, P., Wittekind, C., Yamamoto, Y., & Ohashi, Y. (2017) · Gastric Cancer · doi:10.1007/s10120-016-0601-9 · Cited by 481
Bartley, A. N., Washington, M. K., Colasacco, C., Ventura, C. B., Ismaila, N., Benson, A. B., Carrato, A., Gulley, M. L., Jain, D., Kakar, S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4836 · Cited by 458
Self-citationOhtsu, A., Shimada, Y., Shirao, K., Boku, N., Hyodo, I., Saito, H., Yamamichi, N., Miyata, Y., Ikeda, N., Yamamoto, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.130 · Cited by 427
Risk Factors for Gastric Cancer: A Systematic Review
(2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.3.591 · Cited by 422
Oaknin, A., Tinker, A. V., Gilbert, L., Samouëlian, V., Mathews, C., Brown, J., Barretina-Ginesta, M.-P., Moreno, V., Gravina, A., Abdeddaim, C., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4515 · Cited by 364
Janjigian, Y. Y., Werner, D., Pauligk, C., Steinmetz, K., Kelsen, D. P., Jäger, E., Altmannsberger, H. M., Robinson, E., Tafe, L. J., Tang, L. H., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds104 · Cited by 356
In, H., Solsky, I., Palis, B., Langdon-Embry, M., Ajani, J., & Sano, T. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6078-x · Cited by 351
Self-citationDank, M., Zaluski, J., Barone, C., Valvere, V., Yalcin, S., Peschel, C., Wenczl, M., Goker, E., Cisar, L., Wang, K., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn166 · Cited by 343
Okamura, R., Boichard, A., Kato, S., Sicklick, J. K., Bazhenova, L., & Kurzrock, R. (2018) · JCO Precision Oncology · doi:10.1200/po.18.00183 · Cited by 328
Stahl, A., Ott, K., Weber, W., Becker, K., Link, T., Siewert, J.-R., Schwaiger, M., & Fink, U. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1029-5 · Cited by 321
A meta-analysis on alcohol drinking and gastric cancer risk
Tramacere, I., Negri, E., Pelucchi, C., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Corrao, G., La Vecchia, C., & Boffetta, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr135 · Cited by 312
Fuchs, C. S., Moore, M. R., Harker, G., Villa, L., Rinaldi, D., & Hecht, J. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.058 · Cited by 296
Fuchs, C. S., Shitara, K., Di Bartolomeo, M., Lonardi, S., Al-Batran, S.-E., Van Cutsem, E., Ilson, D. H., Alsina, M., Chau, I., Lacy, J., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30791-5 · Cited by 288
Self-citationMurphy, K. M., Zhang, S., Geiger, T., Hafez, M. J., Bacher, J., Berg, K. D., & Eshleman, J. R. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050092 · Cited by 281
Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus
Ajani, J. A., Ilson, D. H., Daugherty, K., Pazdur, R., Lynch, P. M., & Kelsen, D. P. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.14.1086 · Cited by 280
Self-citationHER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
Jørgensen, J. T., & Hersom, M. (2012) · Journal of Cancer · doi:10.7150/jca.4090 · Cited by 279
Grabsch, H., Sivakumar, S., Gray, S., Gabbert, H. E., & Müller, W. (2010) · Analytical Cellular Pathology · doi:10.1155/2010/519498 · Cited by 263
Okines, A. F. C., Norman, A. R., McCloud, P., Kang, Y.-K., & Cunningham, D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp047 · Cited by 258
Roth, A. D., Fazio, N., Stupp, R., Falk, S., Bernhard, J., Saletti, P., Köberle, D., Borner, M. M., Rufibach, K., Maibach, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0135 · Cited by 243
Lorenzen, S., Schuster, T., Porschen, R., Al-Batran, S.-E., Hofheinz, R., Thuss-Patience, P., Moehler, M., Grabowski, P., Arnold, D., Greten, T., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp069 · Cited by 241
Willis, J., Lefterova, M. I., Artyomenko, A., Kasi, P. M., Nakamura, Y., Mody, K., Catenacci, D. V. T., Fakih, M., Barbacioru, C., Zhao, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1324 · Cited by 239
Self-citationLauren classification and individualized chemotherapy in gastric cancer
MA, J., SHEN, H., KAPESA, L., & ZENG, S. (2016) · Oncology Letters · doi:10.3892/ol.2016.4337 · Cited by 229
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography
Chen, J., Cheong, J., Yun, M. J., Kim, J., Lim, J. S., Hyung, W. J., & Noh, S. H. (2005) · Cancer · doi:10.1002/cncr.21074 · Cited by 223
Chua, T. C., & Merrett, N. D. (2012) · International Journal of Cancer · doi:10.1002/ijc.26292 · Cited by 200
Makiyama, A., Sukawa, Y., Kashiwada, T., Kawada, J., Hosokawa, A., Horie, Y., Tsuji, A., Moriwaki, T., Tanioka, H., Shinozaki, K., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03077 · Cited by 200
Mezhir, J. J., Shah, M. A., Jacks, L. M., Brennan, M. F., Coit, D. G., & Strong, V. E. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1183-0 · Cited by 184
Self-citationA systematic review of methods to palliate malignant gastric outlet obstruction
Ly, J., O’Grady, G., Mittal, A., Plank, L., & Windsor, J. A. (2010) · Surgical Endoscopy · doi:10.1007/s00464-009-0577-1 · Cited by 178
Shah, M. A., Janjigian, Y. Y., Stoller, R., Shibata, S., Kemeny, M., Krishnamurthi, S., Su, Y. B., Ocean, A., Capanu, M., Mehrotra, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.7465 · Cited by 178
Cardoso, R., Coburn, N., Seevaratnam, R., Sutradhar, R., Lourenco, L. G., Mahar, A., Law, C., Yong, E., & Tinmouth, J. (2012) · Gastric Cancer · doi:10.1007/s10120-011-0115-4 · Cited by 167
Al-Batran, S.-E., Pauligk, C., Homann, N., Hartmann, J. T., Moehler, M., Probst, S., Rethwisch, V., Stoehlmacher-Williams, J., Prasnikar, N., Hollerbach, S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.025 · Cited by 165
Chung, H. C., Bang, Y.-J., S Fuchs, C., Qin, S.-K., Satoh, T., Shitara, K., Tabernero, J., Van Cutsem, E., Alsina, M., Cao, Z. A., et al. (2021) · Future Oncology · doi:10.2217/fon-2020-0737 · Cited by 165
Ajani, J. A., Baker, J., Pisters, P. W. T., Ho, L., Mansfield, P. F., Feig, B. W., & Charnsangavej, C. (2002) · Cancer · doi:10.1002/cncr.10279 · Cited by 160
Self-citationPozzo, C., Barone, C., Szántó, J., Pádi, É., Peschel, C., Bükki, J., Горбунова, В. А., Valvere, V., Załuski, J., Biakhov, M. Y., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh473 · Cited by 158
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features
Bergquist, J. R., Leiting, J. L., Habermann, E. B., Cleary, S. P., Kendrick, M. L., Smoot, R. L., Nagorney, D. M., Truty, M. J., & Grotz, T. E. (2019) · Surgery · doi:10.1016/j.surg.2019.04.036 · Cited by 154
Assersohn, L., Brown, G. M., Cunningham, D., Ward, C., Oates, J. R., Waters, J. S., Hill, M. E., & Norman, A. R. (2003) · Annals of Oncology · doi:10.1093/annonc/mdh007 · Cited by 147
Kim, G. M., Jeung, H., Rha, S. Y., Kim, H. S., Jung, I., Nam, B., Lee, K. H., & Chung, H. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.017 · Cited by 140
Continuing rising trend in oesophageal adenocarcinoma
Powell, J., McConkey, C., Gillison, E. W., & Spychal, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10721 · Cited by 140
HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
Kunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., Balise, R. R., Bangs, C. D., Cherry, A. M., & Pai, R. K. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31821c821c · Cited by 139
FDG-PET has no definite role in preoperative imaging in gastric cancer
Dassen, A. E., Lips, D. J., Hoekstra, C. J., Pruijt, H., & Bosscha, K. P. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.11.010 · Cited by 139
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson, D. H., Forastiere, A. A., Arquette, M. A., Costa, F., Heelan, R. T., Huang, Y., & Kelsen, D. P. (2000) · PubMed · Cited by 135
Self-citationKato, S., Okamura, R., Baumgartner, J. M., Patel, H., Leichman, L., Kelly, K. J., Sicklick, J. K., Fanta, P. T., Lippman, S. M., & Kurzrock, R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1128 · Cited by 130
Self-citationAngiographic Embolization for Gastroduodenal Hemorrhage
Poultsides, G. A. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.5.457 · Cited by 123
Self-citationUsefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer
Tsendsuren, T., Jun, S.-M., & Mian, X.-H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i1.43 · Cited by 121
Alcohol consumption and risk of stomach cancer: A meta-analysis
Deng, W., Jin, L., Zhuo, H., Vasiliou, V., & Zhang, Y. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109365 · Cited by 120
Enzinger, P. C., Burtness, B. A., Niedzwiecki, D., Ye, X., Douglas, K., Ilson, D. H., Villaflor, V. M., Cohen, S. J., Mayer, R. J., Venook, A. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.5092 · Cited by 112
Self-citationA study of HER2 gene amplification and protein expression in gastric cancer
Yan, B., Yau, E. X., Omar, S. S. B., Ong, C. W., Pang, B., Yeoh, K. G., & Salto‐Tellez, M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.076570 · Cited by 107
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer
Ilson, D. H., Wadleigh, R. G., Leichman, L., & Kelsen, D. P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm004 · Cited by 100
Self-citationMoehler, M. H., Eimermacher, A., Siebler, J., Höhler, T., Wein, A., Menges, M., Flieger, D., Junginger, T., Geer, T., Gracien, E., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602649 · Cited by 97
Alcohol drinking and gastric cancer risk: a meta-analysis of observational studies
Wang, P., Xiao, F., Gong, B., & Liu, F. (2017) · Oncotarget · doi:10.18632/oncotarget.20918 · Cited by 97
Imaging of esophageal and gastric cancer
Weber, W., & Ott, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.016 · Cited by 88
Staging and follow-up of gastrointestinal tumors with PET/CT
Rosenbaum, S. J., Stergar, H., Antoch, G., Veit, P., Bockisch, A., & Kühl, H. (2005) · Abdominal Imaging · doi:10.1007/s00261-005-0031-3 · Cited by 87
Sym, S. J., Hong, J., Park, J., Cho, E. K., Lee, J. H., Park, Y. H., Lee, W. K., Chung, M., Kim, H.-S., Park, S. H., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2027-3 · Cited by 80
Park, Y. H., Lee, J., Ryoo, B., Ryu, M., Yang, S. H., Kim, B. S., Shin, D. B., Chang, H. M., Kim, T. W., Yuh, Y. J., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0515-7 · Cited by 70
Enzinger, P. C., Kulke, M. H., Clark, J. W., Ryan, D. P., Kim, H. T., Earle, C. C., Vincitore, M., Michelini, A. L., Mayer, R. J., & Fuchs, C. S. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3038-2 · Cited by 66
Self-citationZhao, J., Wu, M., Kim, C. H., Jin, Z.-Y., Zhou, J., Han, R., Yang, J., Zhang, X.-F., Wang, X.-S., Liu, A., et al. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000262 · Cited by 64
PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
Le, D. T., Uram, J. N., Wang, H., Kemberling, H., Eyring, A. D., Bartlett, B. R., Goldberg, R. M., Crocenzi, T. S., Fisher, G. A., Lee, J. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.4_suppl.195 · Cited by 64
Self-citationHall, P. S., Swinson, D., Waters, J. S., Wadsley, J., Falk, S., Roy, R., Tillett, T., Nicoll, J., Cummings, S., Grumett, S. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.4006 · Cited by 59
Kim, W. H., Izquierdo, L. G., Vilardell, F., Chu, K., Soucy, G., dos Santos, L. V., Monges, G. M., Viale, G., Brito, M. J., Osborne, S., et al. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000423 · Cited by 58
Soularue, É., Cohen, R., Tournigand, C., Zaanan, A., Louvet, C., Bachet, J., Hentic, O., Samalin, E., Chibaudel, B., de Gramont, A., et al. (2015) · Bulletin du Cancer · doi:10.1016/j.bulcan.2014.08.001 · Cited by 57
Moehler, M. H., Kanzler, S., Geißler, M., Raedle, J., Ebert, M., Daum, S., Flieger, D., Seufferlein, T. T. W., Galle, P. R., & Hoehler, T. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp269 · Cited by 54
Tabernero, J. M., Ohtsu, A., Muro, K., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0895 · Cited by 48
He, Z., Zhao, T., Xu, H., Wang, Z.-N., Xu, Y., Song, Y., Ni, Z., Xu, H., Yin, S., Liu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20880 · Cited by 43
Sym, S. J., Ryu, M., Lee, J., Chang, H. M., Kim, T. W., Lee, S. S., Lee, J. S., & Kang, Y. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815878a2 · Cited by 38
İnal, A., Ma, K., KUCUKONER, M., & Işıkdoğan, A. (2011) · Neoplasma · doi:10.4149/neo_2012_030 · Cited by 34
Klempner, S. J., Maron, S. B., Chase, L. M., Lomnicki, S., Wainberg, Z. A., & Catenacci, D. V. T. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0602 · Cited by 33
Self-citationWang, G., Yang, B.-F., Fu, Z., Wang, X., & Zhang, Z. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01425-x · Cited by 29
Shinozaki‐Ushiku, A., Ishikawa, S., Komura, D., Seto, Y., Aburatani, H., & Ushiku, T. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01061-9 · Cited by 25
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
Lauro, L. D., Vici, P., Belli, F., Tomao, S., Fattoruso, S. I., Arena, M. G., Pizzuti, L., Giannarelli, D., Paoletti, G., Barba, M., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0321-3 · Cited by 24
Ilson, D. H., Tabernero, J. M., Prokharau, A., Arkenau, H., Ghidini, M., Fujitani, K., Cutsem, E. V., Thuss-Patience, P. C., Beretta, G. D., Mansoor, W., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3531 · Cited by 23
Self-citationArnold, A., Daum, S., von Winterfeld, M., Berg, E., Hummel, M., Horst, D. A., Rau, B., Stein, U., & Treese, C. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152662 · Cited by 22
Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
Cho, J. H., Lim, J. Y., & Choi, Y. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i41.7407 · Cited by 19
Brell, J. M., Krishnamurthi, S., Javle, M. M., Saltzman, J. N., WOLLNER, I. S., Pelley, R. J., Dowlati, A., Kantharaj, B. N., SCHLUCHTER, M. D., Rath, L., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0807-6 · Cited by 17
Lustberg, M. B., Bekaii‐Saab, T., Young, D., Otterson, G. A., Burak, W. E., Abbas, A., McCracken-Bussa, B., Lustberg, M. E., & Villalona-Calero, M. A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d7776d · Cited by 16
PET and PET–CT in Esophageal and Gastric Cancer
Wieder, H. A., Krause, B. J., & Herrmann, K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-062-1_5 · Cited by 16
Cited by
Gastric cancer treatment: recent progress and future perspectives
Guan, W.-L., He, Y., & Xu, R.-H. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01451-3 · Cited by 944
Updates on global epidemiology, risk and prognostic factors of gastric cancer
Yang, W.-J., Zhao, H.-P., Yu, Y., Wang, J.-H., Guo, L., Liu, J.-Y., Pu, J., & Lv, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i16.2452 · Cited by 513
Morton, D., Seymour, M., Magill, L., Handley, K., Glasbey, J., Glimelius, B., Palmer, A., Seligmann, J., Laurberg, S., Murakami, K., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.00046 · Cited by 467
Wang, F., Zhang, X., Tang, L., Wu, Q., Cai, M., Li, Y., Qu, X., Qiu, H., Zhang, Y., Ying, J., et al. (2024) · Cancer Communications · doi:10.1002/cac2.12516 · Cited by 428
Xu, J., Jiang, H., Pan, Y., Gu, K., Cang, S., Han, L., Shu, Y., Li, J., Zhao, J., Pan, H., et al. (2023) · JAMA · doi:10.1001/jama.2023.19918 · Cited by 406
Metadata
- Authors
- Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., Farjah, F., Gerdes, H., Gibson, M. K., Hochwald, S., Hofstetter, W. L., Ilson, D. H., Keswani, R. N., Kim, S., Kleinberg, L. R., Klempner, S. J., Lacy, J., Ly, Q. P., Matkowskyj, K. A., McNamara, M., Mulcahy, M. F., Outlaw, D., Park, H., Perry, K. A., Pimiento, J., Poultsides, G. A., Reznik, S., Roses, R. E., Strong, V. E., Su, S., Wang, H. L., Wiesner, G., Willett, C. G., Yakoub, D., Yoon, H., McMillian, N., & Pluchino, L. A.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2022-02
- Volume
- 20
- Issue
- 2
- Pages
- 167-192
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4210511445
- Cited by
- 1,684
- References
- 115
- FWCI
- 206.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.